India's coronavirus vaccine enters human trials at AIIMS

Covaxin, an experimental novel coronavirus vaccine developed by Hyderabad-based Bharat Biotech, is beginning human trials at All India Institute of Medical Sciences, New Dehi this week. AIIMS-New Delhi is one the 12 sites chosen by the Indian Council of Medical Research, which is a collaborator on the Covaxin novel coronavirus vaccine project, for conducting human trials of the Covid-19 vaccine candidate. Watch video.